Jeffrey Brindle

3.6k total citations · 2 hit papers
18 papers, 2.7k citations indexed

About

Jeffrey Brindle is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Jeffrey Brindle has authored 18 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 7 papers in Radiation and 6 papers in Surgery. Recurrent topics in Jeffrey Brindle's work include Prostate Cancer Diagnosis and Treatment (9 papers), Prostate Cancer Treatment and Research (7 papers) and Advanced Radiotherapy Techniques (7 papers). Jeffrey Brindle is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (9 papers), Prostate Cancer Treatment and Research (7 papers) and Advanced Radiotherapy Techniques (7 papers). Jeffrey Brindle collaborates with scholars based in United States. Jeffrey Brindle's co-authors include Arnold Herskovic, Muhyi Al‐Sarraf, Bahman Emami, Jay S. Cooper, Roger W. Byhardt, Karen Martz, Lawrence Leichman, Vainutis K. Vaitkevicius, Lawrence P. Davis and L. Davis and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Jeffrey Brindle

18 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus

1992 1.6k citations Arnold Herskovic, Karen Martz et al. New England Journal of Medicine profile →
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.

1997 525 citations Muhyi Al‐Sarraf, Karen Martz et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey Brindle United States	11	2.3k	1.9k	472	279	187	18	2.7k
H. Gunter Seydel United States	22	1.7k 0.7×	1.4k 0.7×	224 0.5×	669 2.4×	212 1.1×	50	2.3k
Lucio Trodella Italy	22	878 0.4×	535 0.3×	358 0.8×	721 2.6×	353 1.9×	68	1.5k
Jaap Hoogenhout Netherlands	8	1.1k 0.5×	661 0.3×	299 0.6×	749 2.7×	194 1.0×	10	1.7k
Kathryn Winter United States	14	704 0.3×	905 0.5×	246 0.5×	424 1.5×	106 0.6×	21	1.4k
Ignacio Azinovic Spain	19	466 0.2×	401 0.2×	185 0.4×	553 2.0×	132 0.7×	57	1.1k
Norihiko Kamikonya Japan	19	688 0.3×	528 0.3×	205 0.4×	403 1.4×	312 1.7×	101	1.2k
J I Geh United Kingdom	20	932 0.4×	1.3k 0.7×	74 0.2×	791 2.8×	127 0.7×	32	1.7k
Jessica M. Frakes United States	21	689 0.3×	579 0.3×	171 0.4×	849 3.0×	305 1.6×	144	1.6k
Seong Soo Shin South Korea	18	482 0.2×	484 0.3×	280 0.6×	305 1.1×	243 1.3×	40	1.1k
Kae Okuma Japan	22	604 0.3×	491 0.3×	253 0.5×	310 1.1×	277 1.5×	91	1.3k

Countries citing papers authored by Jeffrey Brindle

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Brindle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Brindle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Brindle more than expected).

Fields of papers citing papers by Jeffrey Brindle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Brindle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Brindle. The network helps show where Jeffrey Brindle may publish in the future.

Co-authorship network of co-authors of Jeffrey Brindle

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Brindle. A scholar is included among the top collaborators of Jeffrey Brindle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Brindle. Jeffrey Brindle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Straka, Christopher, L. Chinsoo Cho, Yair Lotan, et al.. (2016). Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial. Practical Radiation Oncology. 7(1). e43–e49. 11 indexed citations

Hannan, Raquibul, Vasu Tumati, Xian‐Jin Xie, et al.. (2016). Stereotactic body radiation therapy for low and intermediate risk prostate cancer—Results from a multi-institutional clinical trial. European Journal of Cancer. 59. 142–151. 116 indexed citations

Cho, L. Chinsoo, Christopher Straka, Alana Christie, et al.. (2014). Predictors of Rectal Tolerance Observed in a Dose-Escalated Phase 1-2 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 89(3). 509–517. 151 indexed citations

Hong, David S., J.H. Heinzerling, Yair Lotan, et al.. (2011). Predictors of Acute Toxicity after Stereotactic Body Radiation Therapy for Low and Intermediate-risk Prostate Cancer: Secondary Analysis of a Phase I Trial. International Journal of Radiation Oncology*Biology*Physics. 81(2). S210–S210. 3 indexed citations

Boike, Thomas, Yair Lotan, Jeffrey Brindle, et al.. (2011). Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. Journal of Clinical Oncology. 29(15). 2020–2026. 188 indexed citations

Boike, Thomas, et al.. (2009). A Phase I Dose Escalation Study of Stereotactic Body Radiation Therapy (SBRT) for Low- and Intermediate-risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 75(3). S80–S80. 2 indexed citations

Jatoi, Aminah, James A. Martenson, Michelle R. Mahoney, et al.. (2004). Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group.. PubMed. 1(1). 9–9. 8 indexed citations

Schomberg, Paula J., Thomas G. Shanahan, James N. Ingle, et al.. (1997). Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage I or II breast cancer: pilot study.. Radiology. 202(2). 565–569. 6 indexed citations

Al‐Sarraf, Muhyi, Karen Martz, Arnold Herskovic, et al.. (1997). Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.. Journal of Clinical Oncology. 15(1). 277–284. 525 indexed citations breakdown →

10.

Martz, Karen, Arnold Herskovic, Lawrence Leichman, et al.. (1997). Progress Report of Combined Chemoradiotherapy Versus Radiotherapy Alone in Patients With Esophageal Cancer. Journal of Clinical Oncology. 15(2). 866–866. 3 indexed citations

11.

Shaw, Edward, James R. Jett, Jeffrey Brindle, et al.. (1994). Pilot studies of the north central cancer treatment group (NCCTG) utilizing accelerated hyperfractionated thoracic radiation therapy (AHTRT) in unresectable stage IIIA/B non-small cell lung cancer (NSCLC). Lung Cancer. 11. 176–176. 2 indexed citations

12.

Brindle, Jeffrey, et al.. (1993). Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinoma. Cancer. 72(2). 405–409. 13 indexed citations

13.

Shaw, Edward G., Jeffrey Brindle, Edward T. Creagan, et al.. (1992). Locally Recurrent Non-Small-Cell Lung Cancer After Complete Surgical Resection. Mayo Clinic Proceedings. 67(12). 1129–1133. 30 indexed citations

14.

Herskovic, Arnold, Karen Martz, Muhyi Al‐Sarraf, et al.. (1992). Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus. New England Journal of Medicine. 326(24). 1593–1598. 1566 indexed citations breakdown →

15.

Herskovic, Arnold, Thomas F. Pajak, Muhyi Al‐Sarraf, et al.. (1991). Significant adbantage of chemo-radiotherapy compared to radiation alone in randomized phase III trial for patients with esophageal cancer: An intergroup study. International Journal of Radiation Oncology*Biology*Physics. 21. 190–190. 10 indexed citations

16.

Brindle, Jeffrey, Álvaro Martínez, Mark F. Schray, et al.. (1989). Pelvic lymphadenectomy and transperineal interstitial implantation of ir 192 combined with external beam radiotherapy for bulky stage c prostatic carcinoma. International Journal of Radiation Oncology*Biology*Physics. 17(5). 1063–1066. 18 indexed citations

17.

Brindle, Jeffrey, Ralph C. Benson, Alvaro A. Martinez, et al.. (1985). Acute toxicity and preliminary therapeutic results of pelvic lymphadenectomy combined with transperineal interstitial implantation of 192IR and external beam radiotherapy for locally advanced prostate cancer. Urology. 25(3). 233–238. 10 indexed citations

18.

Martinez, Alvaro A., Ralph C. Benson, Gregory K. Edmundson, & Jeffrey Brindle. (1985). Pelvic lymphadenectomy combined with transperineal interstitial implantation of iridium-192 and external beam radiotherapy for locally advanced prostatic carcinoma: technical description. International Journal of Radiation Oncology*Biology*Physics. 11(4). 841–847. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact